These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 29433432)
1. Predictors of breast cancer cell types and their prognostic power in breast cancer patients. Wang F; Dohogne Z; Yang J; Liu Y; Soibam B BMC Genomics; 2018 Feb; 19(1):137. PubMed ID: 29433432 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers. Xu L; Fengji L; Changning L; Liangcai Z; Yinghui L; Yu L; Shanguang C; Jianghui X PLoS One; 2015; 10(11):e0142433. PubMed ID: 26606135 [TBL] [Abstract][Full Text] [Related]
3. A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients. Sun J; Chen X; Wang Z; Guo M; Shi H; Wang X; Cheng L; Zhou M Sci Rep; 2015 Nov; 5():16553. PubMed ID: 26549855 [TBL] [Abstract][Full Text] [Related]
4. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma. Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459 [TBL] [Abstract][Full Text] [Related]
5. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma. Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNAs as prognostic markers in human breast cancer. Liu H; Li J; Koirala P; Ding X; Chen B; Wang Y; Wang Z; Wang C; Zhang X; Mo YY Oncotarget; 2016 Apr; 7(15):20584-96. PubMed ID: 26942882 [TBL] [Abstract][Full Text] [Related]
7. Prognostic factor analysis for breast cancer using gene expression profiles. Joe S; Nam H BMC Med Inform Decis Mak; 2016 Jul; 16 Suppl 1(Suppl 1):56. PubMed ID: 27454576 [TBL] [Abstract][Full Text] [Related]
8. Identification of breast cancer candidate genes using gene co-expression and protein-protein interaction information. Yue Z; Li HT; Yang Y; Hussain S; Zheng CH; Xia J; Chen Y Oncotarget; 2016 Jun; 7(24):36092-36100. PubMed ID: 27150055 [TBL] [Abstract][Full Text] [Related]
9. A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma. Zhou M; Zhang Z; Zhao H; Bao S; Sun J BMC Cancer; 2018 Jan; 18(1):39. PubMed ID: 29304762 [TBL] [Abstract][Full Text] [Related]
10. Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients. Zhou M; Zhong L; Xu W; Sun Y; Zhang Z; Zhao H; Yang L; Sun J Sci Rep; 2016 Aug; 6():31038. PubMed ID: 27503456 [TBL] [Abstract][Full Text] [Related]
11. Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity. Nguyen QH; Pervolarakis N; Blake K; Ma D; Davis RT; James N; Phung AT; Willey E; Kumar R; Jabart E; Driver I; Rock J; Goga A; Khan SA; Lawson DA; Werb Z; Kessenbrock K Nat Commun; 2018 May; 9(1):2028. PubMed ID: 29795293 [TBL] [Abstract][Full Text] [Related]
12. Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer. Iwamoto T; Kelly C; Mizoo T; Nogami T; Motoki T; Shien T; Taira N; Hayashi N; Niikura N; Fujiwara T; Doihara H; Matsuoka J Clin Breast Cancer; 2016 Apr; 16(2):95-100.e1. PubMed ID: 26631838 [TBL] [Abstract][Full Text] [Related]
13. Pseudogene-gene functional networks are prognostic of patient survival in breast cancer. Smerekanych S; Johnson TS; Huang K; Zhang Y BMC Med Genomics; 2020 Apr; 13(Suppl 5):51. PubMed ID: 32241256 [TBL] [Abstract][Full Text] [Related]
14. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma. Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431 [TBL] [Abstract][Full Text] [Related]
15. Mixture classification model based on clinical markers for breast cancer prognosis. Zeng T; Liu J Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686 [TBL] [Abstract][Full Text] [Related]
16. Transcriptome sequencing uncovers a three-long noncoding RNA signature in predicting breast cancer survival. Guo W; Wang Q; Zhan Y; Chen X; Yu Q; Zhang J; Wang Y; Xu XJ; Zhu L Sci Rep; 2016 Jun; 6():27931. PubMed ID: 27338266 [TBL] [Abstract][Full Text] [Related]
17. bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer. Jézéquel P; Campone M; Gouraud W; Guérin-Charbonnel C; Leux C; Ricolleau G; Campion L Breast Cancer Res Treat; 2012 Feb; 131(3):765-75. PubMed ID: 21452023 [TBL] [Abstract][Full Text] [Related]
18. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer. Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive landscape of subtype-specific coding and non-coding RNA transcripts in breast cancer. Vu TN; Pramana S; Calza S; Suo C; Lee D; Pawitan Y Oncotarget; 2016 Oct; 7(42):68851-68863. PubMed ID: 27634900 [TBL] [Abstract][Full Text] [Related]
20. MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer. Han J; Choi YL; Kim H; Choi JY; Lee SK; Lee JE; Choi JS; Park S; Choi JS; Kim YD; Nam SJ; Nam BH; Kwon MJ; Shin YK Breast Cancer Res Treat; 2017 Jul; 164(1):41-56. PubMed ID: 28409241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]